Neurocrine Biosciences Inc (NASDAQ:NBIX)
| 114.56 Delayed Data As of Aug 14 |  -0.18 / -0.16%Today’s Change | 72.14 Today|||52-Week Range 136.26 | +6.58% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Grigoriadis Dimitri E Chief Research Officer |  Sale | 5/19/2020 | 32,749 | $126.73 | $4.2M | -4.62% |
Sherwin Stephen A Director | Sale | 4/28/2020 | 17,687 | $99.39 | $1.8M | +15.98% |
Lloyd Smith Malcolm Chief Regulatory Officer | Sale | 2/10/2020 | 15,927 | $104.56 | $1.7M | +7.93% |
Abernethy Matthew C Chief Financial Officer | Sale | 5/07/2020 | 15,000 | $110.21 | $1.7M | +5.00% |
Lloyd Smith Malcolm Chief Regulatory Officer | Sale | 2/10/2020 | 13,042 | $104.56 | $1.4M | +7.93% |
Lloyd Smith Malcolm Chief Regulatory Officer |  Buy | 2/10/2020 | 15,927 | $81.49 | $1.3M | +7.93% |
Grigoriadis Dimitri E Chief Research Officer | Sale | 5/19/2020 | 10,000 | $125.98 | $1.3M | -4.62% |
Grigoriadis Dimitri E Chief Research Officer | Sale | 5/18/2020 | 10,000 | $119.98 | $1.2M | -8.05% |
Abernethy Matthew C Chief Financial Officer | Buy | 5/07/2020 | 15,000 | $73.60 | $1.1M | +5.00% |
Grigoriadis Dimitri E Chief Research Officer | Sale | 11/01/2019 | 10,188 | $100.34 | $1.0M | +10.35% |
Page of 10